Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Debiopharm plans to expand, optimize activities at Martigny manufacturing facility

Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.

6 Mar 2014

Bio-Rad announces release of beta version of the USP Spectral Library

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the release of beta version of USP Spectral Library™ powered by Bio Rad's KnowItAll® software technology platform for spectral analysis, identification, search, data management, and reporting.

From Bio-Rad Laboratories 5 Mar 2014

POZEN reports total revenue of $4.7 million for fourth quarter 2013

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the fourth quarter and year ended December 31, 2013.

5 Mar 2014

Nanomedicine – Past, Present and Future

News-Medical speaks to Frank Boehm about the fundamentals of nanomedicine and the nanotechnologies of the future.

4 Mar 2014

Sonoco launches Envoy Series for refrigerated and CRT shipping applications

Sonoco ThermoSafe, a unit of Sonoco (NYSE: SON) and a leading global provider of temperature assurance packaging, has added frozen (less than minus 20 degrees Celsius) configurations to its popular Envoy Series of pre-qualified shippers.

4 Mar 2014

Dendreon plans to make PROVENGE available in Europe

Dendreon Corporation today announced that it plans to make PROVENGE (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) available in Europe, beginning with Germany and the United Kingdom.

3 Mar 2014

Akorn's consolidated revenue for fourth quarter 2013 increases 19% to $85 million

Akorn, Inc., a niche generic pharmaceutical company, today reported financial results for the fourth quarter and year-ended December 31, 2013.

3 Mar 2014

Microencapsulated drug delivery may soon revolutionize cancer treatment

Invasive and systemic cancer treatment is a necessary evil for many people with the devastating diagnosis. These patients endure therapies with ravaging side effects, including nausea, immune suppression, hair loss and even organ failure, in hopes of eradicating cancerous tissues in the body.

3 Mar 2014

Astellas Pharma to exclusively commercialize isavuconazole in the U.S. and Canada

Astellas Pharma Inc. announced today that the company has amended the License, Co-Development and Co-Promotion Agreement on isavuconazole under co-development with Basilea Pharmaceutica Ltd.

28 Feb 2014

Dyax reports total revenues of $16.9 million for fourth quarter 2013

Dyax Corp. today announced financial results for the fourth quarter and year ended December 31, 2013.

28 Feb 2014

Auxilium Pharmaceuticals’ net revenues increase $125.9M to 56%

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced financial results for the fourth quarter and full year ending December 31, 2013. The Company also highlighted select commercial, regulatory and clinical development progress and future goals and provided financial guidance for 2014.

28 Feb 2014

Link found between pollutants and certain metabolic complications of obesity

A team of researchers at the IRCM in Montr-al led by R-mi Rabasa-Lhoret, in collaboration with J-r-me Ruzzin from the University of Bergen in Norway, found a link between a type of pollutants and certain metabolic complications of obesity. Their breakthrough, published online this week by the Journal of Clinical Endocrinology & Metabolism, could eventually help improve the prevention, diagnosis, and treatment of cardiometabolic risk associated with obesity, such as diabetes, hypertension and cardiovascular disease.

28 Feb 2014

Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013

Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today reported financial results for the three months and year ended December 31, 2013, and provided an update of recent corporate developments.

27 Feb 2014

AMIC provides report on FDA pre-market notification related to brachytherapy cancer product

Advanced Medical Isotope Corporation ("AMIC"), a company engaged in the development, production and distribution of medical isotopes focused on yttrium-90 brachytherapy devices, today announced that it has received a response from the FDA to its pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 (Y-90) RadioGel(tm) patented brachytherapy cancer product.

25 Feb 2014

Infrared technique could help improve flow reactor chemistry for pharmaceuticals and other products

A pathway to more effective and efficient synthesis of pharmaceutical drugs and other flow reactor chemical products has been opened by a study in which for the first time the catalytic reactivity inside a microreactor was mapped in high resolution from start-to-finish.

25 Feb 2014

Greatbatch announces results for fourth quarter and full-year ended 2014

Greatbatch, Inc., today announced results for its fourth quarter and full-year ended January 3, 2014 highlighted by 5% constant currency organic revenue growth for the full year 2013; 12% year over year improvement in adjusted operating income; and 19% improvement in adjusted diluted EPS over 2012.

25 Feb 2014

Rapid advances and potential in 3D printing and additive manufacturing technologies

A new era of manufacturing is upon us. Recent developments in 3D printing and additive manufacturing technologies are set to usher in the next generation of industrial competitiveness.

23 Feb 2014

Impax Laboratories records adjusted net loss of $1.6 million in fourth quarter 2013

Impax Laboratories, Inc. today reported fourth quarter and full year ended December 31, 2013 results.

21 Feb 2014

CAS announces landmark five-year agreement for SciFinder with AstraZeneca

Chemical Abstracts Service, the world's authority for chemical information, announced today a landmark five-year agreement for SciFinder, the choice for chemistry research, with AstraZeneca, a leading biopharmaceutical company specializing in the discovery, development, manufacturing and marketing of prescription medicines. The long-term agreement guarantees AstraZeneca researchers access to the most accurate, comprehensive and current research, available only in SciFinder.

20 Feb 2014

Hu-Friedy, EMS partner to deliver clinically advanced prophylaxis protocol to U.S. and Canadian markets

Hu-Friedy, a global leader in the manufacturing of dental instruments and products, and Switzerland-based Electro Medical Systems today announced a strategic alliance to deliver the most clinically advanced prophylaxis protocol to the U.S. and Canadian markets by leveraging Hu-Friedy's heritage in high-quality hand instrumentation, coupled with best-in-class EMS offerings in Piezo power scaling and air polishing.

20 Feb 2014

Manufacturing News and Research

Further Reading

Debiopharm plans to expand, optimize activities at Martigny manufacturing facility

Bio-Rad announces release of beta version of the USP Spectral Library

POZEN reports total revenue of $4.7 million for fourth quarter 2013

Nanomedicine – Past, Present and Future

Sonoco launches Envoy Series for refrigerated and CRT shipping applications

Dendreon plans to make PROVENGE available in Europe

Akorn's consolidated revenue for fourth quarter 2013 increases 19% to $85 million

Microencapsulated drug delivery may soon revolutionize cancer treatment

Astellas Pharma to exclusively commercialize isavuconazole in the U.S. and Canada

Dyax reports total revenues of $16.9 million for fourth quarter 2013

Auxilium Pharmaceuticals’ net revenues increase $125.9M to 56%

Link found between pollutants and certain metabolic complications of obesity

Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013

AMIC provides report on FDA pre-market notification related to brachytherapy cancer product

Infrared technique could help improve flow reactor chemistry for pharmaceuticals and other products

Greatbatch announces results for fourth quarter and full-year ended 2014

Rapid advances and potential in 3D printing and additive manufacturing technologies

Impax Laboratories records adjusted net loss of $1.6 million in fourth quarter 2013

CAS announces landmark five-year agreement for SciFinder with AstraZeneca

Hu-Friedy, EMS partner to deliver clinically advanced prophylaxis protocol to U.S. and Canadian markets

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News